|
Market Closed -
Toronto S.E.
15:52:32 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 8.600 CAD | +2.50% |
|
+13.16% | +0.94% |
| 09-17 | COSCIENS Biopharma Raises $4.4 Million Via Second Tranche of Convertible Debenture Offering | MT |
| 09-10 | COSCIENS Biopharma Acquires Pharma Tech Business Nualtis For $15 Million Cash | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COSCIENS BIOPHARMA INC. | Other Biotechnology & Medical Research | +2.50% | +13.16% | +0.94% | -21.46% | -96.37% | 6.06M |  | | |
- Stock Market
- Stocks
- CSCI Stock
- Charts COSCIENS Biopharma Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
